Clinical Trial Update: Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lisafotoclax in combination with decitabine and omacetaxine mepesuccinate (homoharringtonine) for acute myeloid leukemia patients previ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)
• Lisafotoclax (lisafotoclax)
• Omacetaxine mepesuccinate (homoharringtonine)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Acute Myeloid Leukemia (AML) | Phase 2 | Status: NOT_YET_RECRUITING